SIX4, a Potential Therapeutic Target for Estrogen Receptor-Positive Breast Cancer Patients, is Associated with low Promoter Methylation Level

References

• Hanahan D , WeinbergRA. Hallmarks of cancer: the next generation. Cell144(5), 646–674 (2011).
   PubMed Web of Science ®Google Scholar
• Siegel RL , MillerKD , FuchsHE , JemalA. Cancer statistics, 2022. CA Cancer J. Clin.72(1), 7–33 (2022).
   PubMed Web of Science ®Google Scholar
• Onkar SS , CarletonNM , LucasPCet al. The great immune escape: understanding the divergent immune response in breast cancer subtypes. Cancer Discov.13(1), 23–40 (2022).
   Web of Science ®Google Scholar
• Wurmser M , ChaverotN , MadaniRet al. SIX1 and SIX4 homeoproteins regulate PAX7+ progenitor cell properties during fetal epaxial myogenesis. Development147(19), dev185975 (2020).
   PubMed Web of Science ®Google Scholar
• Chen R , HouY , ConnellM , ZhuS. Homeodomain protein Six4 prevents the generation of supernumerary Drosophila type II neuroblasts and premature differentiation of intermediate neural progenitors. PLoS Genet.17(2), e1009371 (2021).
   PubMed Web of Science ®Google Scholar
• Magli A , BaikJ , MillsLJet al. Time-dependent Pax3-mediated chromatin remodeling and cooperation with Six4 and Tead2 specify the skeletal myogenic lineage in developing mesoderm. PLoS Biol.17(2), e3000153 (2019).
   PubMed Web of Science ®Google Scholar
• Takahashi M , TamuraM , SatoS , KawakamiK. Mice doubly deficient in Six4 and Six5 show ventral body wall defects reproducing human omphalocele. Dis. Model. Mech.11(10), dmm034611 (2018).
   PubMed Web of Science ®Google Scholar
• Liu P , CaiS , LiN. Circular RNA-hsa-circ-0000670 promotes gastric cancer progression through the microRNA-384/SIX4 axis. Exp. Cell Res.394(2), 112141 (2020).
   PubMed Web of Science ®Google Scholar
• Han J , HuX. IGF2BP3-stabilized SIX4 promotes the proliferation, migration, invasion and tube formation of ovarian cancer cells. Mol. Med. Rep.26(1), 232 (2022).
   PubMed Web of Science ®Google Scholar
• Wang Z , SunBS , ChenZSet al. FOXA1 leads to aberrant expression of SIX4 affecting cervical cancer cell growth and chemoresistance. Anal. Cell. Pathol. (Amst.)2022, 9675466 (2022).
   Web of Science ®Google Scholar
• He Q , LinZ , WangZet al. SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET. Oncogene39(50), 7279–7295 (2020).
   PubMed Web of Science ®Google Scholar
• Tang X , YangY , SongXet al. SIX4 acts as a master regulator of oncogenes that promotes tumorigenesis in non-small-cell lung cancer cells. Biochem. Biophys. Res. Commun.516(3), 851–857 (2019).
   PubMed Web of Science ®Google Scholar
• Sun XL , MaJ , ChenQZet al. SIX4 promotes metastasis through STAT3 activation in breast cancer. Am. J. Cancer Res.10(1), 224–236 (2020).
   PubMed Web of Science ®Google Scholar
• Li Y , JiangX , YanX , WangY. Upregulation of SIX4 indicates poor clinical outcome and promotes tumor growth and cell metastasis in esophageal squamous cell carcinoma. Thorac. Cancer12(6), 752–759 (2021).
   PubMed Web of Science ®Google Scholar
• Fang ZX , LiCL , WuZ , HouYY , WuHT , LiuJ. Comprehensive analysis of the potential role and prognostic value of sine oculis homeobox homolog family in colorectal cancer. World J. Gastrointest. Oncol.14(11), 2138–2156 (2022).
   PubMed Web of Science ®Google Scholar
• Cao Y , ChenC , TaoY , LinW , WangP. Immunotherapy for triple-negative breast cancer. Pharmaceutics13(12), 2003 (2021).
   PubMed Web of Science ®Google Scholar
• Karlsson M , ZhangC , MearLet al. A single-cell type transcriptomics map of human tissues. Sci. Adv.7(31), eabh2169 (2021).
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS , KarthikeyanSK , KorlaPKet al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia25, 18–27 (2022).
   PubMed Web of Science ®Google Scholar
• Lanczky A , GyorffyB. Web-based survival analysis tool tailored for medical research (KMplot): development and implementation. J. Med. Internet Res.23(7), e27633 (2021).
   PubMed Web of Science ®Google Scholar
• Asleh K , LluchA , GoytainAet al. Triple negative PAM50 non-basal breast cancer subtype predicts benefit from extended adjuvant capecitabine. Clin. Cancer Res.29(2), 389–400 (2022).
   Web of Science ®Google Scholar
• Cerami E , GaoJ , DogrusozUet al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov.2(5), 401–404 (2012).
   PubMed Web of Science ®Google Scholar
• Vasaikar SV , StraubP , WangJ , ZhangB. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res.46(D1), D956–D963 (2018).
   PubMed Web of Science ®Google Scholar
• Warde-Farley D , DonaldsonSL , ComesOet al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res.38(Web Server issue), W214–220 (2010).
   PubMed Web of Science ®Google Scholar
• Li T , FuJ , ZengZet al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res.48(W1), W509–W514 (2020).
   PubMed Web of Science ®Google Scholar
• Liu J , WeiXL , HuangWH , ChenCF , BaiJW , ZhangGJ. Cytoplasmic Skp2 expression is associated with p-Akt1 and predicts poor prognosis in human breast carcinomas. PLOS ONE7(12), e52675 (2012).
   PubMed Web of Science ®Google Scholar
• Chen DS , MellmanI. Elements of cancer immunity and the cancer-immune set point. Nature541(7637), 321–330 (2017).
   PubMed Web of Science ®Google Scholar
• Miller LD , ChouJA , BlackMAet al. Immunogenic subtypes of breast cancer delineated by gene classifiers of immune responsiveness. Cancer Immunol. Res.4(7), 600–610 (2016).
   PubMed Web of Science ®Google Scholar
• Gerrard DT , BerryAA , JenningsREet al. Dynamic changes in the epigenomic landscape regulate human organogenesis and link to developmental disorders. Nature Commun.11(1), 3920 (2020).
   PubMed Web of Science ®Google Scholar
• Camolotto SA , BelovaVK , Torre-HealyLet al. Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4alpha and SIX1/4. Gut70(5), 900–914 (2021).
   PubMed Web of Science ®Google Scholar
• Ehrlich M . DNA hypermethylation in disease: mechanisms and clinical relevance. Epigenetics14(12), 1141–1163 (2019).
   PubMed Web of Science ®Google Scholar
• Allison KE , CoomberBL , BridleBW. Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes. Immunology152(2), 175–184 (2017).
   PubMed Web of Science ®Google Scholar
• Mamula D , KhosousiS , HeY , LazarevicV , SvenningssonP. Impaired migratory phenotype of CD4+ T cells in Parkinson’s disease. NPJ Parkinsons Dis.8(1), 171 (2022).
   PubMed Web of Science ®Google Scholar
• Boieri M , MarcheseE , PhamQMet al. Thymic stromal lymphopoietin-stimulated CD4+ T cells induce senescence in advanced breast cancer. Front. Cell Dev. Biol.10, 1002692 (2022).
   PubMed Web of Science ®Google Scholar
• Van der Leun AM , ThommenDS , SchumacherTN. CD8+ T cell states in human cancer: insights from single-cell analysis. Nat. Rev. Cancer20(4), 218–232 (2020).
   PubMed Web of Science ®Google Scholar
• Baitsch L , BaumgaertnerP , DevevreEet al. Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients. J. Clin. Invest.121(6), 2350–2360 (2011).
   PubMed Web of Science ®Google Scholar
• Blackburn SD , ShinH , FreemanGJ , WherryEJ. Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade. Proc. Natl Acad. Sci. USA105(39), 15016–15021 (2008).
   PubMed Web of Science ®Google Scholar
• Lee M , DuH , WinerDA , Clemente-CasaresX , TsaiS. Mechanosensing in macrophages and dendritic cells in steady-state and disease. Front. Cell Dev. Biol.10, 1044729 (2022).
   PubMed Web of Science ®Google Scholar
• Liu M , LiuL , SongY , LiW , XuL. Targeting macrophages: a novel treatment strategy in solid tumors. J. Transl. Med.20(1), 586 (2022).
   PubMed Web of Science ®Google Scholar
• Dianat-Moghadam H , MahariA , SalahlouR , KhaliliM , AziziM , SadeghzadehH. Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy. Stem Cell Res. Ther.13(1), 150 (2022).
   PubMed Web of Science ®Google Scholar